HealthStream (NASDAQ:HSTM) Reaches New 52-Week High – Still a Buy?

HealthStream, Inc. (NASDAQ:HSTM) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $34.24 and last traded at $33.93, with a volume of 72517 shares traded. The stock had previously closed at $33.93.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Barclays boosted their target price on shares of HealthStream from $32.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Canaccord Genuity Group upped their target price on HealthStream from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Finally, JMP Securities restated a “market perform” rating on shares of HealthStream in a research note on Thursday, February 6th. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $31.50.

HealthStream Stock Performance

The business has a fifty day simple moving average of $32.36 and a 200-day simple moving average of $30.62. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of 51.66, a PEG ratio of 4.43 and a beta of 0.39.

Institutional Trading of HealthStream

Institutional investors and hedge funds have recently bought and sold shares of the stock. Barclays PLC boosted its position in HealthStream by 145.0% during the third quarter. Barclays PLC now owns 58,838 shares of the technology company’s stock valued at $1,697,000 after acquiring an additional 34,821 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in shares of HealthStream by 26.9% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 76,260 shares of the technology company’s stock valued at $2,425,000 after purchasing an additional 16,166 shares during the period. State Street Corp boosted its position in shares of HealthStream by 1.2% during the 3rd quarter. State Street Corp now owns 974,235 shares of the technology company’s stock valued at $28,097,000 after purchasing an additional 11,976 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of HealthStream by 18.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,204 shares of the technology company’s stock valued at $1,650,000 after acquiring an additional 9,017 shares in the last quarter. Finally, Harbor Capital Advisors Inc. grew its stake in shares of HealthStream by 141.2% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company’s stock valued at $11,537,000 after buying an additional 234,148 shares during the period. 69.58% of the stock is currently owned by institutional investors and hedge funds.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.